Cordycepin mediates neuroprotection against apoptosis via ERK/CREB signaling activation in Aβ_1-42-induced neuronal cell models

Abstract

The aggregation of β-amyloid (Aβ) peptides has been associated with the onset of Alzheimer's disease (AD) by causing neurotoxicity due to oxidative stress and apoptosis. Cordycepin is a natural derivative of the nucleoside adenosine that displays potent antioxidant, antitumor, anti-inflammatory, and neuroprotective properties. However, the mechanism of the neuroprotective effect of cordycepin toward Aβ-induced neurotoxicity, as well as underlying mechanisms, is still unclear. In this study, we found that cordycepin conferred neuroprotection to catecholaminergic PC12 neuronal cell cultures exposed to Aβ_1–42-insult by reducing the production of reactive oxygen species, restoring the mitochondrial membrane potential, and inhibiting apoptosis. Cordycepin stimulated the phosphorylation of extracellular signal-regulated kinase (ERK) and cyclic AMP-responsive element-binding protein (CREB) in a time- and concentration-dependent manner. Inhibition of the ERK pathway reduced the neuroprotective effect of cordycepin. Similar results were obtained with hippocampal HT22 neuronal cell cultures. Cumulatively, these findings suggest that cordycepin-induced neuroprotection toward Aβ_1–42 neurotoxic insult may involve activation of the ERK/CREB pathway. This study expands our knowledge of the neuroprotective function of cordycepin and suggests that it holds promise as a natural lead compound for drug development in AD.

Keywords

Aβ_1–42-induced apoptosis / cordycepin / ERK/CREB pathway / neuronal cell lines / neuroprotection

References

[1] Scheltens P, Blennow K, Breteler MMB, et al. Alzheimer's disease. Lancet. 2016; 388: 505-517.

[2] Wójcik P, Jastrzębski MK, Zięba A, Matosiuk D, Kaczor AA. Caspases in Alzheimer's disease: mechanism of activation, role, and potential treatment. Mol Neurobiol. 2023; 61: 4834-4853.

[3] Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med. 2016; 8: 595-608.

[4] Murakami K, Irie K, Morimoto A, et al. Synthesis, aggregation, neurotoxicity, and secondary structure of various Aβ1–42 mutants of familial Alzheimer's disease at positions 21–23. Biochem Biophys Res Commun. 2002; 294: 5-10.

[5] Jan A, Gokce O, Luthi-Carter R, Lashuel HA. The ratio of monomeric to aggregated forms of Aβ40 and Aβ42 is an important determinant of Amyloid-β aggregation, fibrillogenesis, and toxicity. J Biol Chem. 2008; 283: 28176-28189.

[6] Zhang N, Gao Y, Yu S, Sun X, Shen K. Berberine attenuates Aβ42-induced neuronal damage through regulating circHDAC9/miR-142-5p axis in human neuronal cells. Life Sci. 2020; 252:117637.

[7] Wang ZX, Tan L, Liu J, Yu JT. The essential role of soluble Aβ oligomers in Alzheimer's disease. Mol Neurobiol. 2016; 53: 1905-1924.

[8] Zheng WH, Bastianetto S, Mennicken F, Ma W, Kar S. Amyloid β peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience. 2002; 115: 201-211.

[9] Cunningham KG, Manson W, Spring FS, Hutchinson SA. Cordycepin, a metabolic product isolated from cultures of Cordyceps militaris (Linn.) link. Nature. 1950; 166: 949.

[10] Nakamura K, Shinozuka K, Yoshikawa N. Anticancer and antimetastatic effects of cordycepin, an active component of Cordyceps sinensis. J Pharmacol Sci. 2015; 127: 53-56.

[11] Jin Y, Meng X, Qiu Z, Su Y, Yu P, Qu P. Anti-tumor and anti-metastatic roles of cordycepin, one bioactive compound of Cordyceps militaris. Saudi J Biol Sci. 2018; 25: 991-995.

[12] Tan L, Song X, Ren Y, et al. Anti-inflammatory effects of cordycepin: a review. Phytother Res. 2020; 35: 1284-1297.

[13] Li Y, Li K, Mao L, et al. Cordycepin inhibits LPS-induced inflammatory and matrix degradation in the intervertebral disc. PeerJ. 2016; 4:e1992.

[14] Yan Q, Zhang H, Hui K, Shao Q. Cordycepin ameliorates intracerebral hemorrhage induced neurological and cognitive impairments through reducing anti-oxidative stress in a mouse model. J Stroke Cerebrovasc Dis. 2022; 31:106199.

[15] Yang L, Li G, Chai Z, Gong Q, Guo J. Synthesis of cordycepin: current scenario and future perspectives. Fungal Genet Biol. 2020; 143:103431.

[16] Jiang X, Tang PC, Chen Q, et al. Cordycepin exerts neuroprotective effects via an anti-apoptotic mechanism based on the mitochondrial pathway in a rotenone-Induced parkinsonism rat model. CNS Neurol Disord Drug Targets. 2019; 18: 609-620.

[17] Chen ZH, Han YY, Shang YJ, et al. Cordycepin ameliorates synaptic dysfunction and dendrite morphology damage of hippocampal CA1 via A1R in cerebral ischemia. Front Cell Neurosci. 2021; 15:783478.

[18] Soraksa N, Heebkaew N, Promjantuek W, et al. Cordycepin, a bioactive compound from cordyceps spp., moderates Alzheimer's disease-associated pathology via anti-oxidative stress and autophagy activation. J Asian Nat Prod Res. 2024; 26: 583-603.

[19] Yao LH, Wang J, Liu C, et al. Cordycepin protects against β-amyloid and ibotenic acid-induced hippocampal CA1 pyramidal neuronal hyperactivity. Korean J Physiol Pharmacol. 2019; 23: 483-491.

[20] Song H, Huang LP, Li Y, et al. Neuroprotective effects of cordycepin inhibit Aβ-induced apoptosis in hippocampal neurons. Neurotoxicology. 2018; 68: 73-80.

[21] Fanibunda SE, Deb S, Maniyadath B, et al. Serotonin regulates mitochondrial biogenesis and function in rodent cortical neurons via the 5-HT(2A) receptor and SIRT1-PGC-1α axis. Proc Natl Acad Sci USA. 2019; 116: 11028-11037.

[22] Oliver DMA, Reddy PH. Small molecules as therapeutic drugs for Alzheimer's disease. Mol Cell Neurosci. 2019; 96: 47-62.

[23] Shao CS, Zhou XH, Miao YH, Wang P, Zhang QQ, Huang Q. In situ observation of mitochondrial biogenesis as the early event of apoptosis. iScience. 2021; 24:103038.

[24] Deak M. Mitogen-and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 1998; 17: 4426-4441.

[25] Li Y, Zhang X, Ma A, Kang Y. Rational application of β-Hydroxybutyrate attenuates ischemic stroke by suppressing oxidative stress and mitochondrial-dependent apoptosis via activation of the Erk/CREB/eNOS pathway. ACS Chem Neurosci. 2021; 12: 1219-1227.

[26] Barneda-Zahonero B, Miñano-Molina A, Badiola N, et al. Bone morphogenetic protein-6 promotes cerebellar granule neurons survival by activation of the MEK/ERK/CREB pathway. Mol Biol Cell. 2009; 20: 5051-5063.

[27] Zhao X, Li S, Gaur U, Zheng W. Artemisinin improved neuronal functions in Alzheimer's disease animal model 3xtg mice and neuronal cells via stimulating the ERK/CREB signaling pathway. Aging Dis. 2020; 11: 801-819.

[28] Sabbir MG, Fernyhough P. Muscarinic receptor antagonists activate ERK-CREB signaling to augment neurite outgrowth of adult sensory neurons. Neuropharmacology. 2018; 143: 268-281.

[29] Xie D, Deng T, Zhai Z, Sun T, Xu Y. The cellular model for Alzheimer's disease research: PC12 cells. Front Mol Neurosci. 2023; 15:1016559.

[30] Toledo JP, Fernández-Pérez EJ, Ferreira IL, et al. Boldine attenuates synaptic failure and mitochondrial deregulation in cellular models of Alzheimer's disease. Front Neurosci. 2021; 15:617821.

[31] Zhou W, Lei B, Yang C, et al. Artemisia annua extract improves the cognitive deficits and reverses the pathological changes of Alzheimer's disease via regulating YAP signaling. Int J Mol Sci. 2023; 24:5259.

[32] Prasansuklab A, Sukjamnong S, Theerasri A, Hu VW, Sarachana T, Tencomnao T. Transcriptomic analysis of glutamate-induced HT22 neurotoxicity as a model for screening anti-Alzheimer's drugs. Sci Rep. 2023; 13: 7225.

[33] Kumar P, Nagarajan A, Uchil PD. Analysis of cell viability by the MTT assay. Cold Spring Harb Protoc. 2018; 24:103038.

[34] Zeng Z, Xu J, Zheng W. Artemisinin protects PC12 cells against β-amyloid-induced apoptosis through activation of the ERK1/2 signaling pathway. Redox Biol. 2017; 12: 625-633.

[35] Zhao X, Fang J, Li S, et al. Artemisinin attenuated hydrogen peroxide (H₂O₂)-induced oxidative injury in SH-SY5Y and hippocampal neurons via the activation of AMPK pathway. Int J Mol Sci. 2019; 20:2680.

[36] Li S, Peng T, Zhao X, et al. Artemether confers neuroprotection on cerebral ischemic injury through stimulation of the Erk1/2-P90rsk-CREB signaling pathway. Redox Biol. 2021; 46:102069.

[37] Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013; 8: 2281-2308.

[38] Yukhananov R, Chimento DP, Marlow LA. Western blot processing optimization: the perfect blot. Methods Mol Biol. 2022; 2349: 65-80.

[39] Blanchard BJ, Thomas VL, Ingram VM. Mechanism of membrane depolarization caused by the Alzheimer Aβ_1–42 peptide. Biochem Biophys Res Commun. 2002; 293: 1197-1203.

[40] Olatunji OJ, Feng Y, Olatunji OO, Tang J, Ouyang Z, Su Z. Cordycepin protects PC12 cells against 6-hydroxydopamine induced neurotoxicity via its antioxidant properties. Biomed Pharmacother. 2016; 81: 7-14.

[41] Soraksa N, Heebkaew N, Promjantuek W, et al. Cordycepin, a bioactive compound from Cordyceps spp., moderates Alzheimer's disease-associated pathology via anti-oxidative stress and autophagy activation. J Asian Nat Prod Res. 2023; 26: 583-603.

[42] Sun H, Wei S, Gong Y, et al. Neuroprotective effects of cordycepin inhibit glutamate-induced apoptosis in hippocampal neurons. Cell Stress Chaperones. 2024; 29: 10-20.

[43] Jin ML, Park SY, Kim YH, Oh JI, Lee SJ, Park G. The neuroprotective effects of cordycepin inhibit glutamate-induced oxidative and ER stress-associated apoptosis in hippocampal HT22 cells. Neurotoxicology. 2014; 41: 102-111.

[44] Li Q. The dual role of ERK signaling in the apoptosis of neurons. Front Biosci. 2014; 19: 1411-1417.

[45] Rai SN, Dilnashin H, Birla H, et al. The role of PI3K/Akt and ERK in neurodegenerative disorders. Neurotoxic Res. 2019; 35: 775-795.

[46] Vaudry D, Stork PJS, Lazarovici P, Eiden LE. Signaling pathways for PC12 cell differentiation: making the right connections. Science. 2002; 296: 1648-1649.

[47] Jiang H, Zhang L, Koubi D, et al. Roles of Ras-Erk in apoptosis of PC12 cells induced by trophic factor withdrawal or oxidative stress. J Mol Neurosci. 2005; 25: 133-140.

[48] Dhapola R, Beura SK, Sharma P, Singh SK, HariKrishnaReddy D. Oxidative stress in Alzheimer's disease: current knowledge of signaling pathways and therapeutics. Mol Biol Rep. 2024; 51: 48.

[49] Sharma VK, Singh TG. CREB: a multifaceted target for Alzheimer's disease. Curr Alzheimer Res. 2021; 17: 1280-1293.

[50] Fang J, Zhao X, Li S, et al. Protective mechanism of artemisinin on rat bone marrow-derived mesenchymal stem cells against apoptosis induced by hydrogen peroxide via activation of c-Raf-Erk1/2-p90(rsk)-CREB pathway. Stem Cell Res Ther. 2019; 10: 312.

[51] Fu X, Feng Y, Shao B, Zhang Y. Activation of the ERK/Creb/Bcl‑2 pathway protects periodontal ligament stem cells against hydrogen peroxide‑induced oxidative stress. Mol Med Rep. 2019; 19: 3649-3657.

[52] Kumari S, Dhapola R, Reddy DH. Apoptosis in Alzheimer's disease: insight into the signaling pathways and therapeutic avenues. Apoptosis. 2023; 28: 943-957.

[53] Li Q, Rubin L, Silva M, et al. Current progress on neuroprotection induced by Artemisia, Ginseng, Astragalus, and Ginkgo traditional Chinese medicines for the therapy of Alzheimer's disease. Oxid Med Cell Longevity. 2022; 2022:3777021.

[54] Belfiore R, Rodin A, Ferreira E, et al. Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice. Aging Cell. 2019; 18:e12873.

[55] Blurton-Jones M, Kitazawa M, Martinez-Coria H, et al. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci USA. 2009; 106: 13594-13599.

RIGHTS & PERMISSIONS

2025 The Author(s). Ibrain published by Affiliated Hospital of Zunyi Medical University (AHZMU) and Wiley-VCH GmbH.